deltatrials
Completed OBSERVATIONAL NCT04288843

Endometrial Dating by Ex-vivo Imaging of Endometrial Biopsies of In-vitro Fertilization Candidate Participants

Sponsor: Fertigo Medical Ltd

Conditions Endometrium
Updated 11 times since 2020 Last updated: Feb 22, 2024 Started: Jun 16, 2019 Primary completion: Dec 31, 2020 Completion: Jun 6, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Endometrium, this trial is completed. The trial is conducted by Fertigo Medical Ltd and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

In order to assess the efficacy of using ex-vivo endometrial imaging to determine optimal time for embryo transfer, two to four separate analyses, including imaging, and the current standard method of endometrial dating (ultrasound, histological and blood tests) will be performed as well as participant's testimony. Dating by hormonal profile (blood tests) will be contingent on availability of the tests for each subject. So shall be the ultrasound test. During the analysis data will be acquired for subsequent correlation analysis. In addition, a parallel in-vivo analysis, similar in methodology to the ex-vivo analysis, may be performed via imaging by hysteroscopy.

In order to assess the efficacy of using ex-vivo endometrial imaging to determine optimal time for embryo transfer, two to four separate analyses, including imaging, and the current standard method of endometrial dating (ultrasound, histological and blood tests) will be performed as well as participant's testimony. Dating by hormonal profile (blood tests) will be contingent on availability of the tests for each subject. So shall be the ultrasound test. During the analysis data will be acquired for subsequent correlation analysis. In addition, a parallel in-vivo analysis, similar in methodology to the ex-vivo analysis, may be performed via imaging by hysteroscopy.

Status Flow

~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotEnrolling By Invitation~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Mar 2024 · 23 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 7 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshot

Change History

11 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2025 — Present [monthly]

    Completed

  3. Sep 2024 — Sep 2025 [monthly]

    Completed

  4. Jul 2024 — Sep 2024 [monthly]

    Completed

  5. Mar 2024 — Jul 2024 [monthly]

    Completed

Show 6 earlier versions
  1. Apr 2022 — Mar 2024 [monthly]

    Completed

    Status: Enrolling By InvitationCompleted

  2. Dec 2021 — Apr 2022 [monthly]

    Enrolling By Invitation

  3. Jan 2021 — Dec 2021 [monthly]

    Enrolling By Invitation

  4. Nov 2020 — Jan 2021 [monthly]

    Enrolling By Invitation

  5. Aug 2020 — Nov 2020 [monthly]

    Enrolling By Invitation

  6. Mar 2020 — Aug 2020 [monthly]

    Enrolling By Invitation

    First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fertigo Medical Ltd
  • Kaplan Medical Center
Data source: Fertigo Medical Ltd

For direct contact, visit the study record on ClinicalTrials.gov .